España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MBX Biosciences
MBX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.51
-0.09
-0.62%
At close: -
$14.49
-0.02
-0.14%
After Hours: Jan 8, 4:46 PM EDT
Get Report
Comment
MBX Biosciences (MBX) Forecast
News
Earnings
MBX Biosciences (MBX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MBX Biosciences (NASDAQ:MBX) Stock
MBX Biosciences Stock (NASDAQ: MBX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 08, 2025
MBX Biosciences shares are trading higher on ...
Benzinga Newsdesk
Tuesday, January 07, 2025
MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action
Vandana Singh
MBX Biosciences Announced Results From Its Ph...
Benzinga Newsdesk
Thursday, January 02, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, December 19, 2024
Earnings Scheduled For December 19, 2024
Benzinga Insights
Tuesday, December 03, 2024
MBX Biosciences shares are trading higher. Th...
Benzinga Newsdesk
Monday, December 02, 2024
MBX Biosciences Announces MBX 2109 Phase 1 St...
Benzinga Newsdesk
Monday, November 18, 2024
MBX Biosciences Announces The Completion Of T...
Benzinga Newsdesk
Thursday, November 07, 2024
MBX Biosciences Q3 EPS $(2.78) Up From $(9.40...
Benzinga Newsdesk
Tuesday, October 08, 2024
Jefferies Initiates Coverage On MBX Bioscienc...
Benzinga Newsdesk
JP Morgan Initiates Coverage On MBX Bioscienc...
Benzinga Newsdesk
Stifel Initiates Coverage On MBX Biosciences ...
Benzinga Newsdesk
Guggenheim Initiates Coverage On MBX Bioscien...
Benzinga Newsdesk
Monday, September 30, 2024
MBX Biosciences Presents MBX 2109 Phase 2 Ava...
Benzinga Newsdesk
Friday, September 13, 2024
MBX Biosciences IPO Opens At $23/Share; Price...
Benzinga Newsdesk
MBX Biosciences IPO Indicating $20.50/Share O...
Benzinga Newsdesk
MBX Biosciences IPO Indicating $18/Share On 1...
Benzinga Newsdesk
Reported Earlier, MBX Biosciences Prices Init...
Benzinga Newsdesk
Thursday, September 12, 2024
Mbx Biosciences, Inc To Start Trading Tomorrow
Benzinga Insights
Monday, September 09, 2024
Clinical-Stage Biopharmaceutical Company MBX ...
Benzinga Newsdesk
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
